Announce Date | 07/29/2025 |
EPS Normalized Actual | $0.783 (Miss by $-1.817) |
EPS GAAP Actual | $0.783 (Miss by $-1.817) |
Revenue Actual | $2.6269B |
Revenue Surprise | Beat by $2626.9M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.76433 |
EPS GAAP Estimate | $1.76433 |
Revenue Estimate | $2.693511335B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 9.75 | 21.14 | 9.61396 | 9.92625 | 3 |
Dec 2028 | 8.83 | 23.34 | 8.39279 | 9.22294 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.78 | -1.10867 | 2.6269B | -10.41% | -242.73M |
FQ1 2025 (Mar 2025) | 1.05 | 1.05 | 2.5628B | -10.59% | 2562.8M |
FQ4 2024 (Dec 2024) | 2.63 | 2.63 | 2.5476B | -9.39% | 2547.6M |
FQ3 2024 (Sep 2024) | 1.7 | 1.7 | 1.8452B | -52.75% | 1845.2M |
FQ2 2024 (Jun 2024) | 1.93 | 1.93 | 2.9003B | 4.43% | 2900.3M |
FQ1 2024 (Mar 2024) | 1.97 | 1.97 | 2.8341B | 2.36% | 2834.1M |
FQ4 2023 (Dec 2023) | 0.18 | 0.18 | 2.7867B | 2.93% | 2786.7M |
FQ3 2023 (Sep 2023) | 1.26 | 1.26 | 2.8186B | 5.22% | 2818.6M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.76433
Consensus Revenue Estimates
2.693511335B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.86 | -- | 1.83449 | 1.8794 | 2 |
FQ3 2027 (Sep 2027) | 1.96 | -- | 1.93525 | 1.99636 | 3 |
FQ2 2027 (Jun 2027) | 1.91 | -- | 1.88588 | 1.94543 | 5 |
FQ1 2027 (Mar 2027) | 1.61 | -- | 1.58792 | 1.6268 | 2 |
FQ4 2026 (Oct 2026) | 1.8 | -- | 1.78187 | 1.83088 | 3 |
FQ3 2026 (Jul 2026) | 1.76 | -- | 1.74227 | 1.79019 | 5 |
FQ2 2026 (Jun 2026) | 1.76 | 55.68 | 1.73456 | 1.78791 | 4 |
FQ1 2026 (Mar 2026) | 1.78 | 41.01 | 1.75428 | 1.80823 | 3 |
FQ4 2025 (Oct 2025) | 1.80167 | -45.98 | 1.78352 | 1.83258 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.88B | -- | 2.85B | 2.91B | 7 |
FQ3 2027 (Sep 2027) | 2.85B | -- | 2.82B | 2.89B | 7 |
FQ2 2027 (Jun 2027) | 2.82B | -- | 2.79B | 2.86B | 7 |
FQ1 2027 (Mar 2027) | 2.82B | -- | 2.79B | 2.84B | 10 |
FQ4 2026 (Oct 2026) | 2.77B | -- | 2.75B | 2.81B | 4 |
FQ3 2026 (Jul 2026) | 2.74B | -- | 2.72B | 2.78B | 6 |
FQ2 2026 (Jun 2026) | 2.72B | 3.36 | 2.69B | 2.75B | 4 |
FQ1 2026 (Mar 2026) | 2.72B | 5.69 | 2.69B | 2.75B | 6 |
FQ4 2025 (Oct 2025) | 2.71B | 6.16 | 2.69B | 2.75B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.88867 | 0.78 | -1.10867 | -142.14% |
FQ1 2025 (Mar 2025) | 1.05 | 1.05 | 100% | |
FQ4 2024 (Dec 2024) | 2.63 | 2.63 | 100% | |
FQ3 2024 (Sep 2024) | 1.7 | 1.7 | 100% | |
FQ2 2024 (Jun 2024) | 1.93 | 1.93 | 100% | |
FQ1 2024 (Mar 2024) | 1.97 | 1.97 | 100% | |
FQ4 2023 (Dec 2023) | 0.18 | 0.18 | 100% | |
FQ3 2023 (Sep 2023) | 1.26 | 1.26 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $2.87B | $2.63B | $-242.73M | -9.24% |
FQ1 2025 (Mar 2025) | $0B | $2.56B | $2562.8M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.55B | $2547.6M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.85B | $1845.2M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.9B | $2900.3M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.83B | $2834.1M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.79B | $2786.7M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.82B | $2818.6M | 100% |